2.8(top 20%)
impact factor
1.0K(top 20%)
papers
6.4K(top 20%)
citations
37(top 20%)
h-index
4.4(top 10%)
extended IF
1.9K
all documents
6.9K
doc citations
51(top 20%)
g-index

Top Articles

#TitleJournalYearCitations
1A review of the safety of favipiravir – a potential treatment in the COVID-19 pandemic?Journal of Virus Eradication2020183
2The road to elimination of hepatitis C: analysis of cures versus new infections in 91 countriesJournal of Virus Eradication2017123
3Are new antiretroviral treatments increasing the risks of clinical obesity?Journal of Virus Eradication201979
4Virological and immunological characteristics of HIV-infected individuals at the earliest stage of infectionJournal of Virus Eradication201673
5HIV persistence in the setting of antiretroviral therapy: when, where and how does HIV hide?Journal of Virus Eradication201571
6CNS reservoirs for HIV: implications for eradicationJournal of Virus Eradication201569
7Establishment of latent HIV-1 reservoirs: what do we really know?Journal of Virus Eradication201969
8Recent advances in SARS-CoV-2 Spike protein and RBD mutations comparison between new variants Alpha (B.1.1.7, United Kingdom), Beta (B.1.351, South Africa), Gamma (P.1, Brazil) and Delta (B.1.617.2, India)Journal of Virus Eradication202167
9HIV pre-exposure prophylaxis for womenJournal of Virus Eradication201663
10Impact of COVID-19 on people living with HIV: A reviewJournal of Virus Eradication202063
11Minimum costs to manufacture new treatments for COVID-19Journal of Virus Eradication202063
12The road to elimination of hepatitis C: analysis of cures versus new infections in 91 countriesJournal of Virus Eradication201763
13Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis CJournal of Virus Eradication201660
14Factors associated with HIV viral load suppression on antiretroviral therapy in VietnamJournal of Virus Eradication201657
15Willingness to participate and take risks in HIV cure research: survey results from 400 people living with HIV in the USJournal of Virus Eradication201757
16Cytomegalovirus vaccines under clinical developmentJournal of Virus Eradication201654
17CNS reservoirs for HIV: implications for eradicationJournal of Virus Eradication201554
18HIV persistence in the setting of antiretroviral therapy: when, where and how does HIV hide?Journal of Virus Eradication201551
19Markers of HIV reservoir size and immune activation after treatment in acute HIV infection with and without raltegravir and maraviroc intensificationJournal of Virus Eradication201550
20The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goalsJournal of Virus Eradication201949
21Innovative strategies using communications technologies to engage gay men and other men who have sex with men into early HIV testing and treatment in ThailandJournal of Virus Eradication201548
22Achieving UNAIDS 90-90-90 targets for pregnant and postpartum women in sub-Saharan Africa: progress, gaps and research needsJournal of Virus Eradication201847
23Willingness to participate and take risks in HIV cure research: survey results from 400 people living with HIV in the USJournal of Virus Eradication201746
24Virological and immunological characteristics of HIV-infected individuals at the earliest stage of infectionJournal of Virus Eradication201645
25Traversing the cascade: urgent research priorities for implementing the ‘treat all’ strategy for children and adolescents living with HIV in sub-Saharan AfricaJournal of Virus Eradication201844
26Cytomegalovirus vaccines under clinical developmentJournal of Virus Eradication201644
27Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety?Journal of Virus Eradication201844
28Interrupting antiretroviral treatment in HIV cure research: scientific and ethical considerationsJournal of Virus Eradication201742
29HIV/AIDS in the South-East Asia region: progress and challengesJournal of Virus Eradication201640
30Recruitment and ethical considerations in HIV cure trials requiring treatment interruptionJournal of Virus Eradication201539
31Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine HIV pre-exposure prophylaxis: clinical guidelines. Update April 2018Journal of Virus Eradication201839
32Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis CJournal of Virus Eradication201639
33Interrupting antiretroviral treatment in HIV cure research: scientific and ethical considerationsJournal of Virus Eradication201739
34Review of safety and minimum pricing of nitazoxanide for potential treatment of COVID-19Journal of Virus Eradication202038
35Establishment of latent HIV-1 reservoirs: what do we really know?Journal of Virus Eradication201938
36Human cytomegalovirus (CMV) in Africa: a neglected but important pathogenJournal of Virus Eradication201637
37Markers of HIV reservoir size and immune activation after treatment in acute HIV infection with and without raltegravir and maraviroc intensificationJournal of Virus Eradication201536
38Are new antiretroviral treatments increasing the risks of clinical obesity?Journal of Virus Eradication201935
39What motivates participation in HIV cure trials? A call for real-time assessment to improve informed consentJournal of Virus Eradication201534
40The impact of Thailand's public health response to the HIV epidemic 1984–2015: understanding the ingredients of successJournal of Virus Eradication201634
41Recruitment and ethical considerations in HIV cure trials requiring treatment interruptionJournal of Virus Eradication201534
42Innovative strategies using communications technologies to engage gay men and other men who have sex with men into early HIV testing and treatment in ThailandJournal of Virus Eradication201534
43How safe is TDF/FTC as PrEP? A systematic review and meta-analysis of the risk of adverse events in 13 randomised trials of PrEPJournal of Virus Eradication201834
44The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goalsJournal of Virus Eradication201934
45HIV pre-exposure prophylaxis for womenJournal of Virus Eradication201633
46HIV/AIDS in the South-East Asia region: progress and challengesJournal of Virus Eradication201633
47India's HIV programme: successes and challengesJournal of Virus Eradication201631
48High sustained virological response rates using imported generic direct acting antiviral treatment for hepatitis CJournal of Virus Eradication201731
49What motivates participation in HIV cure trials? A call for real-time assessment to improve informed consentJournal of Virus Eradication201531
50Factors associated with HIV viral load suppression on antiretroviral therapy in VietnamJournal of Virus Eradication201630